Stocks and Investing
Stocks and Investing
Wed, June 9, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 8, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (BIIB) at Hold with Increased Target to $395 on, Jun 8th, 2021
Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $265 to $395 on, Jun 8th, 2021.
Carter has made no other calls on BIIB in the last 4 months.
There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 2 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021
This is the rating of the analyst that currently disagrees with Carter
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021
Contributing Sources